Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CardioDx logo — Empowering personalized cardiovascular care through advanced...

CardioDx

Empowering personalized cardiovascular care through advanced genomic diagnostics.

Founded 2004 Series Unknown Total: $313.86M Biotechnology, Health Care +1

General Information

Company Name CardioDx
Founded Year 2004
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when CardioDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CardioDx

CardioDx is a biotechnology startup based in Palo Alto, CA, that has been dedicated to empowering personalized cardiovascular care through advanced genomic diagnostics since its founding in 2004. This pioneering company focuses on creating scientifically validated genomic tests to enhance the assessment and management of various cardiovascular conditions, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. Notably, CardioDx secured a significant $22.50M Venture Round investment on 05 January 2017, with key backing from Artiman Ventures, Longitude Capital, and Temasek Holdings. This funding is expected to further propel CardioDx's endeavors in the biotechnology, healthcare, and pharmaceutical industries.

Taxonomy: Cardiovascular Genomic Diagnostics, Genomic Testing, Coronary Artery Disease, Cardiac Arrhythmias, Heart Failure, Personalized Medicine, Healthcare Innovation, Clinical Diagnostics, Precision Medicine

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor Investor
05 Jan 2017
Series D •••••• - 17 Jun 2016
Debt Financing •••••• - 01 Jan 2015
Venture Round •••••• 1
Investor
18 Dec 2014
Private Equity Round •••••• 1
Investor
24 Jul 2014

View All 10 Funding Rounds

CardioDx Alternatives & Competitors

CardioDx vs
GENinCode Predictive Genetics
GENinCode Predictive Genetics United Kingdom

Clinical Genetics and Precision Medicine. Safeguarding your future health.

Post Ipo Equity
47 employees
Biotechnology, Health Care
CardioDx vs
Compendia Bioscience
Compendia Bioscience

Harnessing global cancer genomic data to enhance diagnostics and treatments for better patient outco...

Seed
Biotechnology
CardioDx vs
Veritas Intercontinental
Veritas Intercontinental Spain

🧬Sequencing your genome is the first step in a life-changing journey | Get more info: www.veritasin...

Series A
68 employees
Biotechnology, Life Sciences

FAQ About CardioDx

Empowering personalized cardiovascular care through advanced genomic diagnostics.
CardioDx was founded in 2004.
CardioDx operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
CardioDx has completed 10 funding rounds, raising a total of $313.86M. The latest funding stage is Series Unknown.
Top alternatives and competitors to CardioDx include GENinCode Predictive Genetics , Compendia Bioscience, Veritas Intercontinental, Genomenon, Inc, MetaGenomika. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioDx and GENinCode Predictive Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CardioDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy